ArticleTurkish journal of urology2017

Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.

Göksel Bayar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.